| Literature DB >> 31456762 |
Caroline Gastaldi Guerrieri1, Monalessa Fábia Pereira1, Anna Clara Milesi Galdino2, André Luis Souza Dos Santos2, Waldir Pereira Elias3, Ricardo Pinto Schuenck1, Liliana Cruz Spano1.
Abstract
Enteroaggregative Escherichia coli (EAEC) is an emerging pathotype responsible for acute and persistent diarrhea. It can be classified as typical and atypical strains, respectively, based on the presence or absence of the AggR regulon, suggesting a higher virulence for typical EAEC. This study aims to evaluate in the Galleria mellonella model if there are differences in the virulence profiles among clinical strains of typical and atypical EAEC, prototype strains EAEC C1096, 042 and its aggR mutant. The clinical EAEC strains (n = 20) were analyzed for the presence of 22 putative virulence factors of EAEC or extraintestinal E. coli by PCR, as well as phenotypic characteristics of virulence (enzymes, siderophore, and biofilm). The survival of the larvae was analyzed after inoculation of 104-107 CFU/larva; the monitoring of bacterial growth in vivo and hemocyte quantification was determined after inoculation of the prototype strains (105 CFU/larva) at different periods after infection. The strains of typical and atypical EAEC presented the same virulence profile for the larva, regardless of the amount or type of genes and phenotypic aspects of virulence analyzed. In addition, the EAEC 042 aggR mutant strain showed a significant reduction in the mortality of the inoculated larvae compared to the wild-type strain. In conclusion, the results obtained herein demonstrate that the virulence of EAEC seems to be related to the AggR regulon, but not exclusively, and atypical EAEC strains may be as virulent as typical ones in vivo in the G. mellonella model.Entities:
Keywords: AggR regulon; Galleria mellonella; bacterial pathogenesis; enteroaggregative E. coli; infection model
Year: 2019 PMID: 31456762 PMCID: PMC6700222 DOI: 10.3389/fmicb.2019.01791
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Primers, amplicon sizes, and control strains to virulence genes detection.
| AAF/I fimbrial subunit | TTAGTCTTCTATCTAGGG AAATTAATTCCGGCATGG | EAEC 17-2 | 450 | ||
| AAF/II fimbrial subunit | ATGTATTTTTAGAGGTTGAC TATTATATTGTCACAAGCTC | EAEC 042 | 518 | ||
| AAF/III fimbrial subunit | GTATCATTGCGAGTCTGGTATTCAG GGGCTGTTATAGAGTAACTTCCAG | 462 | |||
| AAF/IV fimbrial subunit | TCCATTATGTCAGGCTGCAA GGCGTTAACGTCTGATTTCC | Personal collection | 411 | ||
| EAEC transcriptional activator | CTAATTGTACAATCGATGTA ATGAAGTAATTCTTGAAT | EAEC 042 | 308 | ||
| Antiaggregation protein (dispersin) | CTTTTCTGGCATCTTGGGT GTAACAACCCCTTTGGAAGT | EAEC 042 | 232 | ||
| Cryptic ORF | ACTTTCTCCCGAGACATTC CTTTAGCGGGAGCATTCAT | EAEC 042 | 613 | ||
| α-haemolysin | CTCATTGGCCTCACCGAACGG GCTGGCAGCTGTGTCCACGAG | Personal collection | 299 | ||
| Yersiniabactin biosynthetic gene | AAGGATTCGCTGTTACCGGAC TCGTCGGGCAGCGTTTCTTCT | 264 | |||
| ATGTGCCTGCTATTATTTAT CATAATAATAAGCGGTCAGC | Personal collection | 799 | |||
| Antigen 43 | ACGCACAACCATCAATAAAA CCGCCTCCGATACTGAATGC | EAEC 042 | 600 | ||
| Secreted auto transporter toxin | ACTGGCGGACTCATGCTGT AACCCTGTAAGAAGACTGAGC | 387 | |||
| EAEC heat-stable enterotoxin 1 | CCATCAACACAGTATATCCGA GGTCGCGAGTGACGGCTTTGT | EAEC 042 | 111 | ||
| Plasmid encoded toxin | GACCATGACCTATACCGACAGC CCGATTTCTCAAACTCAAGACC | EAEC 042 | 600 | ||
| TCACGCTACCATCAAAGA TATCCCCCTTTGGTGGTA | EAEC 042 | 309 | |||
| ATCTGCTGCGTCATGTTCCT GTAGTGGTCATACCTTTGAGC | 1700 | ||||
| Aerobactin siderophore | AGTCTGCATCTTAACCTTCA CTCGTTATGATCGTTCAGAT | 1100 | |||
| Afa/Dr adhesin | CGGCTTTTCTGCTGAACTGGCAGGC CCGTCAGCCCCCACGGCAGACC | C1845 | 672 | ||
| P fimbriae | GACGGCTGTACTGCAGGGTGTGGCG ATATCCTTTCTGCAGGGATGCAATA | 328 | |||
| S fimbriae | CTCCGGAGAACTGGGTGCATCTTAC CGGAGGAGTAATTACAAACCTGGCA | 410 | |||
| Aerobactin receptor | GGCTGGACATCATGGGAACTGG CGTCGGGAACGGGTAGAATCG | 300 | |||
| Group 2 capsule synthesis | GCGCATTTGCTGATACTGTTG CATCCAGACGATAAGCATGAGCA | 272 |
Genotypic and phenotypic characterization of EAEC strains (gray square for positivity) and % survival of G. mellonella model 96 h after infection.
FIGURE 1Siderophore production by EAEC strains, comparing typical and atypical groups (p > 0.05).
FIGURE 2Biofilm production by EAEC strains, comparing typical and atypical groups (p < 0.05). The dotted line indicates the cut-off point to classify biofilm producers.
FIGURE 3Survival curve graphs of the G. mellonella inoculated with clinical and prototype strains. (A) 10 typical EAEC strains analyzed at the concentration of 105 CFU/larva. (B) 10 atypical EAEC strains analyzed at the concentration of 105 CFU/larva. (C) Survival curve by groups of strains (typical and atypical) (p = 0.04). (D) Prototype strains EAEC 042 (typical), C1096 (atypical), non-pathogenic E. coli strain HB101, and EAEC 042 aggR mutant at the concentration of 105 CFU/larva.
FIGURE 4Percentage of survival of G. mellonella larvae after 96 h of infection. Percentage of survival of G. mellonella after 96 h of infection with typical (A) and atypical (B) EAEC strains at concentration 105 CFU/larva. Data obtained from three independent experiments and expressed as mean ± SD. (C) Comparison of percentage of survival after 96 h of infection between the strains of typical and atypical EAEC (p > 0.05).
FIGURE 5Dendrogram representation of the hierarchical clustering of the isolates according to the presence or absence of virulence gene with the corresponding EAEC strains and survival percentage. Red and blue lines represent the typical and atypical strains, respectively.
FIGURE 6Monitoring of bacterial growth in vivo, hemocyte quantification and melanization of larvae during infection by EAEC prototype strains. (A) Quantification of the bacterial load in the hemolymph at 0, 2, 4, 6, and 24 h after infection with the prototype strains at 105 CFU/larva. (B) Hemocyte quantification during infection by the prototype strains at 105 CFU/larva using the uninoculated (NI) and inoculated with sterile PBS larvae as control. (C) Melanization of larvae during infection by EAEC prototype strains compared to larvae infected with non-pathogenic E. coli HB101, larvae inoculated with sterile PBS and uninoculated larvae (NI). Prototype strains: EAEC 042 (typical), EAEC 042 aggR mutant, EAEC C1096 (atypical), and non-pathogenic E. coli HB101.